Prediction of disease course in inflammatory bowel diseases

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Clinical presentation at diagnosis and disease course of both Crohn's disease (CD) and ulcerative colitis are heterogeneous and variable over time. Since most patients have a relapsing course and most CD patients develop complications (e.g. stricture and/or perforation), much emphasis has been placed in the recent years on the determination of important predictive factors. The identification of these factors may eventually lead to a more personalized, tailored therapy. In this TOPIC HIGHLIGHT series, we provide an update on the available literature regarding important clinical, endoscopic, fecal, serological/routine laboratory and genetic factors. Our aim is to assist clinicians in the everyday practical decision-making when choosing the treatment strategy for their patients suffering from inflammatory bowel diseases.

Original languageEnglish
Pages (from-to)2589-2590
Number of pages2
JournalWorld Journal of Gastroenterology
Volume16
Issue number21
DOIs
Publication statusPublished - Jun 7 2010

Fingerprint

Inflammatory Bowel Diseases
Crohn Disease
Ulcerative Colitis
Decision Making
Pathologic Constriction
Therapeutics

Keywords

  • Clinical
  • Crohn's disease
  • Disease course
  • Genetics
  • Inflammatory bowel disease
  • Predictive markers
  • Serology
  • Ulcerative colitis

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Prediction of disease course in inflammatory bowel diseases. / Lakatos, P.

In: World Journal of Gastroenterology, Vol. 16, No. 21, 07.06.2010, p. 2589-2590.

Research output: Contribution to journalArticle

@article{452f134be43c43b293c2c9277c667c34,
title = "Prediction of disease course in inflammatory bowel diseases",
abstract = "Clinical presentation at diagnosis and disease course of both Crohn's disease (CD) and ulcerative colitis are heterogeneous and variable over time. Since most patients have a relapsing course and most CD patients develop complications (e.g. stricture and/or perforation), much emphasis has been placed in the recent years on the determination of important predictive factors. The identification of these factors may eventually lead to a more personalized, tailored therapy. In this TOPIC HIGHLIGHT series, we provide an update on the available literature regarding important clinical, endoscopic, fecal, serological/routine laboratory and genetic factors. Our aim is to assist clinicians in the everyday practical decision-making when choosing the treatment strategy for their patients suffering from inflammatory bowel diseases.",
keywords = "Clinical, Crohn's disease, Disease course, Genetics, Inflammatory bowel disease, Predictive markers, Serology, Ulcerative colitis",
author = "P. Lakatos",
year = "2010",
month = "6",
day = "7",
doi = "10.3748/wjg.v16.i21.2589",
language = "English",
volume = "16",
pages = "2589--2590",
journal = "World Journal of Gastroenterology",
issn = "1007-9327",
publisher = "WJG Press",
number = "21",

}

TY - JOUR

T1 - Prediction of disease course in inflammatory bowel diseases

AU - Lakatos, P.

PY - 2010/6/7

Y1 - 2010/6/7

N2 - Clinical presentation at diagnosis and disease course of both Crohn's disease (CD) and ulcerative colitis are heterogeneous and variable over time. Since most patients have a relapsing course and most CD patients develop complications (e.g. stricture and/or perforation), much emphasis has been placed in the recent years on the determination of important predictive factors. The identification of these factors may eventually lead to a more personalized, tailored therapy. In this TOPIC HIGHLIGHT series, we provide an update on the available literature regarding important clinical, endoscopic, fecal, serological/routine laboratory and genetic factors. Our aim is to assist clinicians in the everyday practical decision-making when choosing the treatment strategy for their patients suffering from inflammatory bowel diseases.

AB - Clinical presentation at diagnosis and disease course of both Crohn's disease (CD) and ulcerative colitis are heterogeneous and variable over time. Since most patients have a relapsing course and most CD patients develop complications (e.g. stricture and/or perforation), much emphasis has been placed in the recent years on the determination of important predictive factors. The identification of these factors may eventually lead to a more personalized, tailored therapy. In this TOPIC HIGHLIGHT series, we provide an update on the available literature regarding important clinical, endoscopic, fecal, serological/routine laboratory and genetic factors. Our aim is to assist clinicians in the everyday practical decision-making when choosing the treatment strategy for their patients suffering from inflammatory bowel diseases.

KW - Clinical

KW - Crohn's disease

KW - Disease course

KW - Genetics

KW - Inflammatory bowel disease

KW - Predictive markers

KW - Serology

KW - Ulcerative colitis

UR - http://www.scopus.com/inward/record.url?scp=77953529871&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953529871&partnerID=8YFLogxK

U2 - 10.3748/wjg.v16.i21.2589

DO - 10.3748/wjg.v16.i21.2589

M3 - Article

VL - 16

SP - 2589

EP - 2590

JO - World Journal of Gastroenterology

JF - World Journal of Gastroenterology

SN - 1007-9327

IS - 21

ER -